Singapore markets open in 1 hour 4 minutes

Spruce Biosciences, Inc. (SPRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.0300+0.0400 (+2.01%)
At close: 04:00PM EDT
1.9100 -0.12 (-5.91%)
After hours: 04:33PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.9900
Open1.9500
Bid1.8800 x 1300
Ask2.2000 x 1000
Day's range1.9400 - 2.0761
52-week range1.2500 - 8.5900
Volume43,483
Avg. volume152,270
Market cap47.691M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.8860
Earnings date09 Aug 2022 - 15 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.17
  • Business Wire

    Spruce Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update

    SAN FRANCISCO, August 10, 2022--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today reported financial results for the second quarter ended June 30, 2022 and provided corporate updates.

  • Business Wire

    Spruce Biosciences to Participate in June Investor Conferences

    SAN FRANCISCO, June 01, 2022--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that company management will participate in two upcoming investor conferences taking place in June.

  • Business Wire

    Spruce Biosciences Announces Acceptance of Abstract for Presentation at ENDO 2022 Annual Conference

    SAN FRANCISCO, May 31, 2022--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for poster presentation at the 104th Annual Meeting of the Endocrine Society (ENDO 2022) taking place June 11-14, 2022, in Atlanta, GA. In a recorded presentation, the company will highlight results from a recent